We play fair by founders
Giving you an unfair advantage, to take you from where you are to where you want to be
Giving you an unfair advantage, to take you from where you are to where you want to be
92% of our portfolio recommend working with us
Story78% of our companies have successfully raised a Series A
PortfolioBecause we know it takes more than funding for a startup to survive and thrive; the right support goes beyond writing cheques
ThesisIt’s a step towards the tomorrow we all want to live in
ContentCollaboration is Queen: Our female founder network has collectively raised £600m
Female FoundersIt’s never too early for an initial conversation
Pitch usThe power behind the cure
uMed is a technology platform embedded within a global network of healthcare providers that automates the process of building high quality prospective research registries.
While others rely on aggregated data which blocks subject re-engagement, uMed can rapidly reach back to contact patients for clinical studies, engage in data collection from home, and collect biomarker and genomics samples.
uMed provides the missing piece to unlock the huge value in healthcare data — scalable, repeatable, compliant patient engagement.
Their solution is a win-win-win: patients get access to the latest clinical research, trials and therapies to improve health outcomes; healthcare providers are empowered to offer a better service to their patients with minimum time investment; and pharma/researchers can identify and engage with patient cohorts (pre, post or as part of a trial) in a matter of clicks and leverage electronic health records to deliver rapid, cost efficient studies across large patient populations.